Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases

Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue damage, and blood clotting. Engineered biomaterials from the nano- to the macroscale can provide targeted drug delivery, controlled drug release, local immunomodulation, enhanced immunity, and other desirable f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Matter
Autors principals: Zarubova, Jana, Zhang, Xuexiang, Hoffman, Tyler, Hasani-Sadrabadi, Mohammad Mahdi, Li, Song
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Inc. 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7942141/
https://ncbi.nlm.nih.gov/pubmed/33723531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.matt.2021.02.025
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars